健康状况

18 基于循证研究的健康状况与补充剂信息

Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.

How We Grade Evidence

每个健康状况页面按临床证据强度对补充剂成分进行排序。以下是各等级的含义：

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

代谢综合征

34.7% of US adults (NHANES); increases with age: 50% in those >60 years

Central obesity Elevated blood pressure Elevated fasting glucose +4

代谢缓慢

True metabolic rate 10%+ below predicted affects approximately 10-15% of the population

Difficulty losing weight despite caloric deficit Fatigue Cold intolerance +3

减重平台期

Virtually universal — 80-95% of dieters experience a plateau within 6-12 months

Stalled weight loss despite continued caloric deficit Increased hunger Fatigue +3

减重手术后营养支持

~256,000 bariatric procedures performed annually in the US (2023); growing worldwide

Nutrient deficiencies Hair loss Fatigue +4

减重期间的肌肉保持

Universal concern during any weight loss intervention; particularly important in older adults (sarcopenic obesity)

Decreasing strength during diet Muscle soreness Fatigue +2

减重期间的运动表现

Only 23% of US adults meet both aerobic and muscle-strengthening guidelines

Low exercise tolerance Difficulty maintaining workout intensity during dieting Prolonged recovery +2

多囊卵巢综合征相关体重管理

6-12% of reproductive-age women; 60-80% of PCOS patients are overweight/obese

Weight gain (especially abdominal) Irregular periods Acne +4

情绪性进食

38-60% of overweight/obese individuals report emotional eating as a significant barrier to weight management

Eating when not physically hungry Craving specific comfort foods (high sugar/fat) Eating in response to stress/boredom/sadness +2

更年期相关体重增加

Affects the majority of menopausal women; average age of menopause: 51 years; 1.3 million US women enter menopause annually

Weight gain (especially abdominal) Hot flashes Sleep disruption +4

甲状腺功能减退相关体重增加

Clinical hypothyroidism: 4.6% of US population; subclinical: 4-10% of adults; 5-8x more common in women

Weight gain (2-15 kg) Fatigue Cold intolerance +5

皮质醇相关体重增加

Chronic stress affects 75-80% of adults; cortisol-driven visceral fat accumulation is a significant component of metabolic syndrome

Abdominal weight gain Difficulty losing belly fat despite diet/exercise Sugar/carb cravings (especially evenings) +3

糖分渴望

86% of people report food cravings; sugar is the most commonly craved category (especially in women)

Intense desire for sweet foods Difficulty stopping after small amounts Post-meal sugar seeking +2

肥胖症

42.4% of US adults (2023 CDC data); 650 million adults globally; prevalence has tripled since 1975

Excessive body fat (BMI ≥30) Fatigue Joint pain +4

胰岛素抵抗

40% of US adults aged 18-44 (estimated); up to 70% in obese individuals

Difficulty losing weight Carbohydrate cravings Fatigue after meals +4

脂肪氧化增强

Impaired fat oxidation (metabolic inflexibility) is observed in 40-60% of obese individuals

Heavy reliance on carbohydrates for energy Difficulty exercising in fasting state Metabolic inflexibility +2

腹部脂肪减少

54% of US adults have elevated waist circumference; visceral obesity increasing even among normal-weight individuals

Waist circumference >40 in (men) / >35 in (women) Elevated waist-to-hip ratio Elevated liver enzymes +2

超重管理

30.7% of US adults; combined with obesity, 73.1% of US adults are overweight or obese

BMI 25-29.9 Mild fatigue Early insulin resistance +2

食欲控制

Subjective hunger and appetite dysregulation affect the majority of individuals attempting weight loss

Persistent hunger between meals Difficulty feeling full Frequent snacking +3

FDA 免责声明: 这些声明未经美国食品药品监督管理局（FDA）评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析，不构成医疗建议。在开始任何补充剂方案之前，请务必咨询您的医疗保健提供者。